IL-4 derived peptides for use in the treatment of obesity
US12378294B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 4, 2023 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Jan 4, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to peptides derived from interleukin-4 (IL-4) for the treatment of obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.